The 20 Best Melanoma Doctors Near Me in Michigan, US

Christopher Lao is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Lao is rated as an Elite provider by MediFind in the treatment of Melanoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, and Metastatic Uveal Melanoma.

Leslie Fecher, MD, joined the faculty on from Indiana University School of Medicine's Simon Cancer Center. Dr. Fecher completed her BA in Biochemistry at Rice University in Houston, and earned her MD from Indiana University School of Medicine. She completed her residency at University of Texas Southwestern in Dallas, followed by an Oncology Fellowship at Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center in Baltimore. Dr. Fecher was an assistant professor of medicine at the Abramson Cancer Center in Philadelphia for four years where she held a secondary appointment in Dermatology. She subsequently joined the faculty at Indiana University in 2011. Dr. Fecher is rated as an Elite provider by MediFind in the treatment of Melanoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Tissue Biopsy.

Dr. May Chan obtained her medical degree from the State University of New York at Buffalo and was a Howard Hughes Research Scholar in 2005-2006. She completed residency training in Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, followed by a Dermatopathology fellowship at Harvard. She joined the University of Michigan in 2011 and is now a Professor of Pathology and Dermatology. She is the Interim Section Head for Dermatopathology, the Program Director for the Dermatopathology Fellowship, and the Medical Director of the Immunohistochemistry Laboratory. She also serves on the Test Development and Advisory Committee of the American Board of Pathology.Dr. Chan is an editorial board member of Modern Pathology and Journal of Cutaneous Pathology. She has a broad research interest in the areas of inflammatory skin diseases, melanocytic lesions, cutaneous adnexal neoplasms, and immunohistochemistry. She is the author/co-author of over 90 peer-reviewed publications and the book, Handbook of Direct Immunofluorescence: A Pattern-based Approach to Skin and Mucosal Biopsies.Dr. Chan is board certified in Anatomic Pathology and Dermatopathology. In addition to her primary role as a dermatopathologist, Dr. Chan retains her interest in surgical pathology including interpretation of head and neck, soft tissue, pulmonary, and endocrine cases, as well as intraoperative frozen sections. Over the years she has been invited to speak at national and international meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the American Society of Dermatopathology (ASDP), the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), the American Academy of Dermatology (AAD), the European Nail Society, and Dermpedia. Dr. Chan is rated as an Elite provider by MediFind in the treatment of Melanoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Sebaceous Adenoma, and Squamous Cell Skin Carcinoma.

Lawrence Flaherty is a Hematologist practicing medicine in Farmington Hills, Michigan. Dr. Flaherty is rated as an Elite provider by MediFind in the treatment of Melanoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Melanoma, Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer.

Dr. Christopher Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School.Dr. Bichakjian is a foremost expert in the field of cutaneous surgery and oncology. He has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006. He has presented over 100 national and international invited lectures and visiting professorships, and authored or co-authored nearly 90 peer-reviewed publications with a primary focus on cutaneous oncology.Dr. Bichakjian received his medical degree from Radboud University in The Netherlands. After relocating to the US, he completed residency in dermatology and fellowship in micrographic surgery and cutaneous oncology at Michigan Medicine. He subsequently practiced Mohs surgery in private practice and served as adjunct faculty at Weill Medical College at Cornell University in New York City.In 2004, Dr. Bichakjian was recruited back to Ann Arbor to join the faculty in the Department of Dermatology at Michigan Medicine. He served as director of the UM Multidisciplinary Merkel Cell Carcinoma Program for more than a decade (2006-2017), In addition, he served as chief of the Division of Cutaneous Surgery and Oncology and as director of the Multidisciplinary Melanoma Program in the Rogel Cancer Center from 2017-2020. Dr. Bichakjian is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Basal Cell Skin Cancer, Melanoma, and Eccrine Porocarcinoma. Dr. Bichakjian is board certified in Dermatology and Micrographic Dermatologic Surgery.

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Melanoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

Dr. Jennifer Schwartz received her medical degree from Northwestern University Medical School and completed her internship in internal medicine at Northwestern Medical Center in Chicago. She completed her dermatology residency at the University of Michigan Department of Dermatology and two years of specialty training in melanoma at the U-M Rogel Cancer Center.Additionally, she completed advanced specialty training in cutaneous surgery treatment of benign and malignant lesions at the University of Michigan. In 1999, Dr. Schwartz became a faculty member of the Melanoma and Cutaneous Oncology and Surgery Program. Dr. Schwartz is rated as a Distinguished provider by MediFind in the treatment of Melanoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Melanoma, Eccrine Porocarcinoma, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schwartz is board certified in Dermatology.

Gerald Wright is a Surgical Oncologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 16 years. Dr. Wright is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Post-Splenectomy Syndrome, Mastectomy, and Pancreaticoduodenectomy. Dr. Wright is board certified in American Board Of Surgery and American Board Of Surgery.

Richard Keidan is a General Surgeon practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 46 years. Dr. Keidan is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Melanoma, Eccrine Porocarcinoma, Merkel Cell Carcinoma, and Liposarcoma. Dr. Keidan is board certified in American Board Of Surgery. Dr. Keidan is currently accepting new patients.

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Dr. Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981 and her M.D. degree from the University of Texas Medical School at Houston, Houston, Texas in 1985. She did a transitional internship at St. Joseph's Hospital, Houston, Texas from 1985-1986 and then was a Post-doctoral Fellow in the Department of Dermatology at the University of Texas Medical School at Houston. From 1987-1989, she completed her residency training in dermatology at the University of Texas Medical School at Houston, followed by a Dermatopathology Fellowship at the University of Colorado School of Medicine, Denver, Colorado, from 1990-1991. Dr. Lowe is board certified in both Dermatology and Dermatopathology.In 1990, Dr. Lowe served as an Instructor in the Department of Dermatology at the University of Texas Medical School at Houston, Houston, Texas. She moved to the Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, where she was a Senior Staff Physician and Director of Dermatopathology from 1991-1996. In 1996 she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School, Ann Arbor, Michigan, as Assistant Professor, where she was promoted to Associate Professor in 1998, and to Professor in 2004. She served as the Director of Dermatopathology in the Department of Pathology from 1996-2012.While at the University of Michigan Medical School, Dr. Lowe has been actively involved in the dermatopathology service, teaching and academic pursuits. She has been recognized institutionally and nationally as an educator and clinician. In 2013, Dr. Lowe received the Walter Nickel Teaching Award given by the American Society of Dermatopathology and also received the Outstanding Clinician of the Year Award bestowed by the University of Michigan Medical School. In 2015, she was inducted into the University of Michigan League of Clinical Excellence. Dr. Lowe received the William B. Taylor Resident Teaching Award from the Department of Dermatology, University of Michigan in 1999 and 2005 for exemplary teaching. She has been recognized annually since 2003 in America's Top Doctors for Cancer by Castle Connolly Medical Ltd. She has served on national committees, including the American Board of Dermatology, Dermatopathology Test Committee and the American Board of Pathology, Dermatopathology Test Committee and has served on the editorial boards of both the Journal of the American Academy of Dermatology and Cancer. Dr. Lowe is the author or co-author of more than 130 publications in peer-reviewed journals. Dr. Lowe is rated as a Distinguished provider by MediFind in the treatment of Melanoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Syringoma, and Syringocystadenoma Papilliferum. Dr. Lowe is board certified in Dermatology and Dermatopathology.

Timothy Johnson is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Melanoma, Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, and Merkel Cell Carcinoma.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.

Michael S. Sabel, MD, FACS is the William W. Coon Collegiate Professor of Surgical Oncology in the Department of Surgery at Michigan Medicine. He completed his undergraduate training at Pennsylvania State University and obtained his medical degree from Temple University School of Medicine in Philadelphia. His general surgery residency was performed at Rush-Presbyterian-St. Lukes Medical Center in Chicago. Dr. Sabel completed an NIH-T32 research fellowship in tumor immunology and a surgical oncology fellowship at Roswell Park Cancer Institute in Buffalo, NY. Dr. Sabel joined the University of Michigan faculty in 2001. He has been listed in Best Doctors in America in Surgical Oncology every year since 2007 and has named as one of the U.S. News and World Report Top Doctors in Surgery since 2011.Clinical Specialization:Dr. Sabels clinical interests are in the area of surgical oncology, with special expertise in breast cancer and melanoma. Dr. Sabel is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Melanoma, Inflammatory Breast Cancer, Mastectomy, and Craniectomy. Dr. Sabel is board certified in Surgery.

Alfred Chang is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Melanoma, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy.

Dr. Angeles is an Associate Professor with Tenure of Surgery, Associate Professor of Dermatology, and Faculty Member in the Cancer Biology PhD Program at the University of Michigan in the Division of Surgical Oncology. She earned her medical degree at Tufts University School of Medicine. She completed general surgery residency at New York Presbyterian-Weill Cornell Medical Center. While in residency she completed a two-year basic/translational science Surgical Oncology Research Fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) focusing on the molecular biology and novel therapeutics for sarcoma. After residency, Dr. Angeles returned to MSKCC and completed a clinical Complex Surgical Oncology Fellowship. Dr. Angeles is board-certified in both General Surgery and Complex General Surgical Oncology. She is the Director of the Regional Cancer Therapies Clinic at University of Michigan/Rogel Cancer Center. Dr. Angeles is a nationally recognized surgeon-scientist dedicated to advancing cancer care through innovative research and compassionate patient care. As the lead investigator for multiple clinical trials at the Rogel Cancer Center, she is at the forefront of developing new treatments for melanoma and sarcoma. Her laboratory studies the immune system’s role in fighting cancer, with a special focus on how resident memory T cells can help create long-lasting protection against tumors. By combining basic science and translational research, Dr. Angeles and her team are working to transform discoveries in the lab into effective new therapies for patients. Dr. Angeles’s research has been supported by the American Cancer Society, the Melanoma Research Alliance, the Society of Surgical Oncology, and the National Institutes of Health’s National Cancer Institute (NCI-NIH).Committed to excellence in both science and patient care, Dr. Angeles is a Fellow of the American College of Surgeons, a Fellow of the Society of Surgical Oncology, and an active member of professional societies including the American Society of Clinical Oncology (ASCO), the Society of Surgical Oncology (SSO), the Connective Tissue Oncology Society (CTOS), and the Society for Immunotherapy of Cancer (SITC). She also serves as Chair of the Society of Surgical Oncology's Research Committee, helping to shape the future of cancer research and treatment.Clinical Specialization:Dr. Angeles is a board-certified surgical oncologist whose clinical practice focuses on patients with soft tissue cancers including sarcoma, melanoma, and non-melanoma cutaneous malignancies. Dr. Angeles cares for patients in a robust multidisciplinary fashion and provides education and counseling to her patients in order to allow shared decision making for the surgical management of their disease. Dr. Angeles is rated as a Distinguished provider by MediFind in the treatment of Melanoma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Melanoma, Splenectomy, and Nephrectomy. Dr. Angeles is board certified in Surgery and Complex General Surgical Oncology.

Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as a Distinguished provider by MediFind in the treatment of Melanoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy. Dr. Dossett is board certified in Surgery and Complex General Surgical Oncology.

Dr. Jeffrey Moyer earned his medical degree with highest honors in 1997 at the University of North Carolina-Chapel Hill. In 2003, he joined the University of Michigan Rogel Cancer Center, where he performs reconstructive surgery for head and neck cancer. His research focuses on immunological therapy of head and neck cancer. Dr. Moyer is Board-certified by the American Board of Otolaryngology and the American Board of Facial Plastic and Reconstructive Surgery in addition to being an active member of the American Academy of Facial Plastic and Reconstructive Surgeons, the American Academy of Otolaryngology-Head and Neck Surgery, the American College of Surgeons, the American Association for Cancer Research and the American Head and Neck Society. Dr. Moyer is rated as a Distinguished provider by MediFind in the treatment of Melanoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Rhinophyma, Laryngectomy, and Osteotomy. Dr. Moyer is board certified in Otolaryngology-Head & Neck Surgery and Facial Plastic & Recon Surg.

Dr. Cha is a faculty member in the University of Michigan Department of Dermatology. Her interests include general medical dermatology, melanoma, and skin procedures. She sees patients at the University of Michigan Domino's Farms Dermatology Clinic and at the Multidisciplinary Melanoma Clinic in the Cancer Center. In addition, Dr. Cha directs the Department of Dermatology's community outreach involvement with the Hope Clinic. Dr. Cha is a graduate of the University of Michigan Medical School and the Medical Scientist Training Program, through which she earned her medical degree and a PhD in the Department of Human Genetics. Dr. Cha joined the faculty of the University of Michigan Department of Dermatology in 2010, after competing her dermatology residency training. Dr. Cha is rated as a Distinguished provider by MediFind in the treatment of Melanoma. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Epidermoid Cyst, and Actinic Keratosis. Dr. Cha is board certified in Dermatology.

Kelly Malloy is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Malloy is rated as a Distinguished provider by MediFind in the treatment of Melanoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Osteotomy.